Cardior Pharmaceuticals: Pioneering Study Confirms Pivotal Role of Antisense microRNA Approach in the Treatment of Pathologic Hypertrophy of the Heart
First-ever data on therapeutic miR-132 inhibition in a large animal model of nonischemic heart failure with cardiac hype…